Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Clinical trial NCT01794793 · COMPLETED

Trial details

NCT number: NCT01794793
Sponsor: RECORDATI GROUP
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cushing's Disease Acromegaly Neuroendocrine Tumors Pituitary Tumors Ectopic ACTH Secreting (EAS) Tumors Dumping Syndrome Prostate Cancer Melanoma Negative for bRAF Melanoma Negative for nRAS

Start date: 2013-06-10
Primary completion: 2023-07-25
Enrollment: 337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.